Stina Wickström

13PUBLICATIONS
76CO-AUTHORS
Innate immunityTumour immunologyMolecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 09, 2026
BET inhibition synergizes with RLR signaling to enhance tumor immunogenicity and T cell recognition.

|Apr 30, 2026
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8+ T cells.

|Apr 01, 2026
Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway.

Mireia Cruz De Los Santos, Yi Chen, Amaia González De Zárate

|Feb 19, 2026
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.

Hildur Helgadottir, Ana Carneiro, Francesca Portelli

|Dec 07, 2024
Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy.

Aine O'Reilly, Wenchao Zhao, Stina Wickström

|May 15, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

Shi Yong Neo, Le Tong, Joni Chong

Pageof 3

Frequent Collaborators

9 joint publications

Rolf Kiessling

6 joint publications

Andreas Lundqvist

3 joint publications

Lucas Baldran-Groves

2 joint publications

Mireia Cruz De Los Santos